Snapshot 3:Mon, Sep 8, 2025 12:53:47 PM GMT last edited by Vandita

Russia's Cancer Vaccine Shows 100% Efficacy in Clinical Trials

Russia's Enteromix Cancer Vaccine Shows 100% Efficacy in Clinical Trials

Published SEP 8 2025

Russia's Cancer Vaccine Shows 100% Efficacy in Clinical Trials

story

Image credit: Russia's National Medical Research Radiological Centre

The Spin

EarlyThis trialbreakthrough successis doesn'ta guaranteerevolutionary long-termleap effectiveness,in andcancer thetreatment smallthat samplecould sizesave ofcountless 48lives volunteersworldwide. raisesThe questions100% aboutefficacy broaderrate applicability.in Significanthuman logisticaltrials challengesdemonstrates aroundthat personalizedmRNA vaccinetechnology production,can cold-chainbe storagesuccessfully andadapted genomicbeyond profilingCOVID-19 mustvaccines beto addressedtreat beforecancer thiswith becomesunprecedented viableprecision and safety.

RT NDTV

Early trial success doesn't guarantee long-term effectiveness, and the small sample size of 48 volunteers raises questions about broader applicability. Significant logistical challenges, including personalized vaccine production, cold-chain storage, and genomic profiling, must be addressed before this becomes viable.

Tribune India

Metaculus Prediction

There's a 50% chance that there will be a breakthrough in the treatment of hard-to-treat cancers by February 2031, according to the Metaculus prediction community.